In vitro and in silico analyses of the angiotensin-I converting enzyme inhibitory activity of peptides identified from Bellamya bengalensis protein hydrolysates
T. K. Dey, R. Chatterjee, D. Paul, A. Roychowdhury, R. S. Mondal, P. Dhar
Abstract
The study focuses on identification of ACE-inhibitory peptides from the proteolytic digests of muscle protein of Bellamya bengalensis and its underlying mechanism. 120 min Alcalase-hydrolysates were ultrafiltered to isolate the small peptide fraction (<3kDa) and in vitro ACE-inhibitory activity was analyzed. The IC50 value of the 120 min hydrolysate ultafiltered fraction was found to be 86.74 {+/-} 0.575 {micro}g/mL, while the IC50 of Lisinopril is 0.31 {+/-} 0.07 {micro}g/mL. This fraction was assessed in MALDI-ToF mass-spectrometer and five peptides were sequenced via de novo sequencing. The ACE-inhibitory potential of the peptides have a positive correlation with the hydrophobicity of the amino acids. Synthetic analogue of the peptide (IC50 value 8.52 {+/-} 0.779 {micro}g/mL) was used to understand the thermodynamics of the inhibition by checking the binding affinity of the peptide to ACE by Isothermal titration calorimetry compared with lisinopril, and further substantiated by in silico site specific molecular docking study.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Identification, structure-activity relationship and in silico molecular docking analyses of five novel angiotensin I-converting enzyme (ACE)-inhibitory peptides from stone fish hydrolysates
S. M. Auwal, N. Zainal Abidin, … N. saari·bioRxiv·May 8, 2018
- Proteomic Analysis of ACE Inhibitory Peptides extracted from Fermented Goat Milk
Muhammad Zohaib Aslam, Sana Shoukat, … Zhang Bolin·bioRxiv·May 31, 2018
- Efficacy of the first bioactive peptide from the pearl
- Role of selective Bioactive Compounds as an Angiotensin Converting Enzyme Inhibitor
Huma Khan, Tahir Husain, … Mohammad Azhar Khan·bioRxiv·Aug 17, 2020
- Computationally Guided Design of Novel Angiotensin Converting Enzyme Inhibitors
J. D. Lam, M. Riley, J. B. Siegel·bioRxiv·Apr 27, 2022
- Exploiting the Angiotensin-Converting Enzyme Pathway to Augment Endogenous Opioid Signaling
Prakashkumar Dobariya, Jessica M. Williams, … Swati S. More·Communications BiologyPeer-reviewed·Oct 14, 2025